|
Spectros Mission
Spectros markets and licenses
advanced
molecular sensing and imaging devices
that shed light on life-threatening diseases,
including ischemia and cancer.
Our medical devices embed state-of-the-art
biophotonic molecular technologies*
to enable real-time therapies that
speed diagnosis, reduce complications, and lower costs.
Areas of Product Focus
Spectros has four product areas:
►
Ischemia Diagnosis and Detection (T-Stat®)
►
Cancer Detection and Targeting (FirstScan™,
in FDA Trials)
►
Surgical Guidance Automated Tissue I.D. (FireFly®,
outlicensed in limited fields of use)
►
Physiology Monitoring Implants and Nanobots (Optibots™,
in R&D)
To learn more, click here.
|
Additional Resources:
For Investor News,
click here.
Board and Advisors: Spectros has an outstanding medical and scientific advisory board. To see the list,
click here.
Our Patents: *For a partial listing of the over 70 U.S. and world patents covering our proprietary optical monitoring and sensing technologies,
click here.
|
